GPCR功能细胞系

G蛋白偶联受体（GPCR）是一类重要的治疗靶点，为方便和加速GPCR药物发现及生物学研究，格宁生物（ScreeNingBio）提供高质量的细胞模型和化合物筛选技术服务，包括第二信使激活 (cAMP, IP1, Ca2+)、β-Arrestin、受体内吞等试验。
目前，格宁生物开发了human-, mouse-, rat-等种属的500+GPCR细胞库和筛选平台以适应灵活多样的项目类型——如Compound Profiling和高通量筛选，并可根据合作伙伴的需求提供定制服务。
ScreeNingBio CHO-K1 GLP-1R Gs Cell Line
Background
CHO-K1 GLP-1 Gs cell line overexpress GLP1R and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.
Product Information
Catalog Number:                SNB-G-0106A
Lot Number:                        See vial
Contents:                             2 vials, 1 x 106 cells per vial
Target GPCR:                       GLP-1 receptor
HGNC Symbol:                    GLP1R
Coupling:                              Gs
Accession No.:                     NM_002062 (Hs)
GPCR Species:                      Human
Host Cell:                               CHO-K1
Culture Medium:                 F12 + 10% FBS
Antibiotics:                           500 μg/mL G418
Storage:                                 Store in vapor phase of liquid nitrogen upon receiving
 Functional Assay Data
In a 384-well plate, cells were stimulated with agonist compounds using the assay conditions described below. Following stimulation, signal was detected using the Cisbio HTRF cAMP assay detection kit according to the recommended protocol.
CHO-K1 GLP-1 Gs cells were treated with control agonist and incubate at 37℃ for 30 min.
Signal window was 7.6-fold. GLP-1(7-36) EC50 was 0.006 nM; Taspoglutide EC50 was 0.0001 nM.
Passage Stability

This cell line has been confirmed to be stable through 25 passages with no significant drop in assay window or change in EC50 of control compound.
 Price Information
￥79,999 for 2 vial of frozen cell
￥7,999 for one 96 well compound testing (4 compounds, 10 point, ½ log dilution in duplicate)
￥11,999 for one 384 well compound testing (16 compounds, 10 point, ½ log dilution in duplicate)
 For additional information, please visit www.screeningbio.com or info@screeningbio.com
Related Product
Human GLP-1R Stable Line (CHO-K1): Cat#SNB-G-0106A

Mouse GLP-1R Stable Line (CHO-K1): Cat#SNB-G-0106B

Rat GLP-1R Stable Line (CHO-K1): Cat#SNB-G-0106C

Human GLP-1R Stable Line (HEK293): Cat#SNB-G-0106D

Human GLP-2R Stable Line (CHO-K1): Cat#SNB-G-0107A

Mouse GLP-2R Stable Line (CHO-K1): Cat#SNB-G-0107B

Rat GLP-2R Stable Line (CHO-K1): Cat#SNB-G-0107C
Human GIPR Stable Line (HEK293): Cat#SNB-G-0103A

Mouse GIPR Stable Line (HEK293): Cat#SNB-G-0103B

Rat GIPR Stable Line (CHO-K1): Cat#SNB-G-0103C

Ferret GIPR Stable Line (HEK293): Cat#SNB-G-0103E
Human GCGR Stable Line (HEK293): Cat#SNB-G-0105A

Mouse GCGR Stable Line (CHO-K1): Cat#SNB-G-0105B

Rat GCGR Stable Line (CHO-K1): Cat#SNB-G-0105C
Human GHRHR Stable Line (CHO-K1): Cat#SNB-G-0102A

Mouse GHRHR Stable Line (CHO-K1): Cat#SNB-G-0102B

Rat GHRHR Stable Line (CHO-K1): Cat#SNB-G-0102C
Human SCTR Stable Line (CHO-K1): Cat#SNB-G-0104A

Mouse SCTR Stable Line (CHO-K1): Cat#SNB-G-0104B

Rat SCTR Stable Line (CHO-K1): Cat#SNB-G-0104C
 

上海格宁生物科技有限公司成立于2020年10月，经营范围为生物科技领域内的技术开发、技术咨询、技术转让和技术服务。主要从事新药研发领域的重组细胞系构建和细胞生化水平的药物样品活性测试。上海格宁生物科技有限公司开发了1000种以上各类重组细胞系，靶点涉及G蛋白偶联受体、离子通道、核受体、信号通路等。利用这些稳定表达功能型细胞系，公司将构建广泛的药物筛选平台，一方面对外出售功能验证的细胞产品，一方面为国内外医药企业提供研发外包服务，以人类健康为使命，助力合作伙伴的科研进程。